◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › OSRH

OSR Health, Inc. (OSRH) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-20

OSR Health, Inc. (OSRH) operates in the Biotechnology industry and is headquartered in Bellevue, United States with about 22 employees. Its market capitalization is roughly $16 million. In the fiscal year ended 2025-12-31, OSRH reported $3M in revenue and ($18M) in net income.

OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea.

Interactive charts & full statements → Open the OSRH valuation workbench →

OSRH Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$3M$4M$0M$0M
Gross Profit$1M$1M$1M$0M
Operating Income (EBIT)($18M)($12M)($2M)($1M)
Net Income($18M)($10M)$0M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OSRH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$0M$0M$1M$1M$1M
Gross Profit$0M$0M$0M$0M$0M
Operating Income (EBIT)($4M)($6M)($4M)($5M)($3M)
Net Income($3M)($5M)($2M)$0M($11M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OSRH Free Cash Flow History

OSRH Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total Assets$171M$175M$37M$121M
Total Liabilities$44M$32M$4M$22M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OSRH viewer.

Other Companies in Biotechnology

← OSPNAll stocksOSS →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.